Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.7M Buy
140,864
+26,011
+23% +$4.23M 2.88% 7
2025
Q4
$22.4M Buy
114,853
+22,117
+24% +$5.27M 2.32% 14
2025
Q3
$26.1M Buy
92,736
+88,203
+1,946% +$22.5M 2.69% 10
2025
Q2
$991K Buy
+4,533
New +$732K 0.16% 44
2024
Q2
Sell
-177,011
Closed -$22.2M 49
2024
Q1
$22.2M Sell
177,011
-68,950
-28% -$7.89M 6.04% 2
2023
Q4
$25.9M Sell
245,961
-2,330
-0.9% -$254K 6.54% 7
2023
Q3
$26.3M Buy
248,291
+123,035
+98% +$14.2M 5.19% 6
2023
Q2
$14.9M Buy
+125,256
New +$13M 2.63% 11

Other funds holding ORCL

Kadensa Capital's ORCL Position: Q1 2026 in Review

Kadensa Capital increased its Oracle (ORCL) stake by 23% in Q1 2026, buying an estimated $4.23M and bringing the position to 140,864 shares worth $20.7M. The position accounts for 2.88% of the portfolio, ranked #7.

Kadensa Capital first reported a position in ORCL in Q2 2023 and has held it in 8 quarters since. The position peaked at $26.3M in Q3 2023. 3,474 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • Kadensa Capital held 140,864 shares of Oracle worth $20.7M as of Q1 2026.
  • Kadensa Capital bought 26,011 Oracle shares in Q1 2026, an estimated $4.23M.
  • Oracle made up 2.88% of Kadensa Capital's portfolio in Q1 2026, its #7 holding.
  • Kadensa Capital first reported a position in Oracle in Q2 2023 and has held it in 8 quarters since.
  • Kadensa Capital's Oracle position peaked at $26.3M in Q3 2023.
  • 3,474 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Kadensa Capital's 13F filing for Q1 2026, filed 15 May 2026.